Table 3.
Marker | Difference ± SE, AU | P Value |
---|---|---|
Renin | −0.06422 ± 0.08847 | 0.4783 |
AGT | −0.1663 ± 0.1216 | 0.1903 |
ACE1 | −0.2422 ± 0.1306 | 0.0823 |
AT1 | −0.1094 ± 0.2290 | 0.6394 |
MR | −0.08719 ± 0.1232 | 0.4895 |
NOX2 | −0.2412 ± 0.2288 | 0.3075 |
CD11b | −0.3328 ± 0.1770 | 0.0784 |
TNF-α | −0.08678 ± 0.3540 | 0.8094 |
IL-1β | −0.1908 ± 0.2752 | 0.4981 |
IL-6 | −0.1093 ± 0.2349 | 0.648 |
mRNA expression that was nonsignificantly elevated in the paraventricular nucleus (PVN). Difference in mRNA expression (amphetamine – saline rats) is displayed in arbitrary units (AU) along with P values. All molecular markers examined were not significantly elevated by amphetamine pretreatment. ACE1, angiotensin-converting enzyme 1; AGT, angiotensinogen; AT1, angiotensin II receptor type 1; CD11b, cluster of differentiation molecule 11b; IL-1β, interleukin-1β; IL-6 interleukin-6; MR, mineralocorticoid receptor; NOX2, NADPH oxidase 2; TNF-α, tumor necrosis factor-α.